149 related articles for article (PubMed ID: 29380037)
1. A novel heterozygous ITGB3 p.T720del inducing spontaneous activation of integrin αIIbβ3 in autosomal dominant macrothrombocytopenia with aggregation dysfunction.
Miyashita N; Onozawa M; Hayasaka K; Yamada T; Migita O; Hata K; Okada K; Goto H; Nakagawa M; Hashimoto D; Kahata K; Kondo T; Kunishima S; Teshima T
Ann Hematol; 2018 Apr; 97(4):629-640. PubMed ID: 29380037
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia.
Kunishima S; Kashiwagi H; Otsu M; Takayama N; Eto K; Onodera M; Miyajima Y; Takamatsu Y; Suzumiya J; Matsubara K; Tomiyama Y; Saito H
Blood; 2011 May; 117(20):5479-84. PubMed ID: 21454453
[TBL] [Abstract][Full Text] [Related]
3. αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.
Morais S; Oliveira J; Lau C; Pereira M; Gonçalves M; Monteiro C; Gonçalves AR; Matos R; Sampaio M; Cruz E; Freitas I; Santos R; Lima M
PLoS One; 2020; 15(12):e0235136. PubMed ID: 33276370
[TBL] [Abstract][Full Text] [Related]
4. A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.
Ghevaert C; Salsmann A; Watkins NA; Schaffner-Reckinger E; Rankin A; Garner SF; Stephens J; Smith GA; Debili N; Vainchenker W; de Groot PG; Huntington JA; Laffan M; Kieffer N; Ouwehand WH
Blood; 2008 Apr; 111(7):3407-14. PubMed ID: 18065693
[TBL] [Abstract][Full Text] [Related]
5. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the integrin αIIb/β3 intracytoplasmic salt bridge cause macrothrombocytopenia and enlarged platelet α-granules.
Favier M; Bordet JC; Favier R; Gkalea V; Pillois X; Rameau P; Debili N; Alessi MC; Nurden P; Raslova H; Nurden A
Am J Hematol; 2018 Feb; 93(2):195-204. PubMed ID: 29090484
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype.
Kashiwagi H; Kunishima S; Kiyomizu K; Amano Y; Shimada H; Morishita M; Kanakura Y; Tomiyama Y
Mol Genet Genomic Med; 2013 Jul; 1(2):77-86. PubMed ID: 24498605
[TBL] [Abstract][Full Text] [Related]
8. Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia.
Bury L; Falcinelli E; Chiasserini D; Springer TA; Italiano JE; Gresele P
Haematologica; 2016 Jan; 101(1):46-56. PubMed ID: 26452979
[TBL] [Abstract][Full Text] [Related]
9. First description of an IgM monoclonal antibody causing α
Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
Tokgoz H; Torun Ozkan D; Caliskan U; Akar N
Platelets; 2015; 26(8):779-82. PubMed ID: 25734216
[TBL] [Abstract][Full Text] [Related]
11. Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin.
Nurden AT; Pillois X; Fiore M; Heilig R; Nurden P
Semin Thromb Hemost; 2011 Sep; 37(6):698-706. PubMed ID: 22102273
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
[TBL] [Abstract][Full Text] [Related]
13. Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families.
Gresele P; Falcinelli E; Giannini S; D'Adamo P; D'Eustacchio A; Corazzi T; Mezzasoma AM; Di Bari F; Guglielmini G; Cecchetti L; Noris P; Balduini CL; Savoia A
Haematologica; 2009 May; 94(5):663-9. PubMed ID: 19336737
[TBL] [Abstract][Full Text] [Related]
14. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
[TBL] [Abstract][Full Text] [Related]
15. Identification of the integrin β3 L718P mutation in a pedigree with autosomal dominant thrombocytopenia with anisocytosis.
Kobayashi Y; Matsui H; Kanai A; Tsumura M; Okada S; Miki M; Nakamura K; Kunishima S; Inaba T; Kobayashi M
Br J Haematol; 2013 Feb; 160(4):521-9. PubMed ID: 23253071
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
[TBL] [Abstract][Full Text] [Related]
17. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors.
González-Manchón C; Butta N; Larrucea S; Arias-Salgado EG; Alonso S; López A; Parrilla R
Thromb Haemost; 2004 Dec; 92(6):1377-86. PubMed ID: 15583747
[TBL] [Abstract][Full Text] [Related]
18. New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains.
Koker MY; Sarper N; Albayrak C; Zulfikar B; Zengin E; Saraymen B; Albayrak D; Koc B; Avcilar H; Karakükcü M; Chenet C; Bianchi F; de Brevern AG; Petermann R; Jallu V
Platelets; 2022 May; 33(4):551-561. PubMed ID: 34275420
[TBL] [Abstract][Full Text] [Related]
19. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.
Jallu V; Dusseaux M; Panzer S; Torchet MF; Hezard N; Goudemand J; de Brevern AG; Kaplan C
Hum Mutat; 2010 Mar; 31(3):237-46. PubMed ID: 20020534
[TBL] [Abstract][Full Text] [Related]
20. A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopenia.
Guillet B; Bayart S; Pillois X; Nurden P; Caen JP; Nurden AT
J Thromb Haemost; 2019 Dec; 17(12):2211-2215. PubMed ID: 31565851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
